Colorectal and Anal Carcinomas
Colorectal and Anal Carcinomas is a research topic within Surgery. Science Explorer counts 26k research works in it since 1950. 12.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the treatment and management of anal cancer, including the use of chemoradiation, intensity-modulated radiation therapy, and chemotherapy. It also explores the impact of HIV infection on treatment outcomes, imaging techniques such as FDG-PET/CT, and the long-term quality of life for survivors. Additionally, it delves into salvage surgery for recurrent or persistent anal cancer.
- Anal Cancer
- Chemoradiation
- Intensity-Modulated Radiation Therapy
- Squamous-Cell Carcinoma
- Chemotherapy
- HIV-positive Patients
- Metastatic Anal Cancer
- FDG-PET/CT Imaging
- Quality of Life
- Salvage Surgery
- Research works
- 26k fractional, since 1950
- In the world top 10%
- 3.3k per year above
- Top-10% rate
- 12.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +32% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Colorectal and Anal Carcinomas research?
By volume, the United States and China publish the most (1.1k and 1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.1k works
- 2 China 1k works
- 3 Japan 377 works
- 4 India 232 works
- 5 Italy 202 works
- 6 United Kingdom 185 works
- 7 Germany 180 works
- 8 Brazil 172 works
- 9 Spain 144 works
- 10 France 133 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Colorectal and Anal Carcinomas research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Colorectal and Anal Carcinomas research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Cleveland Clinic.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 41 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 40 works
- 3 Cleveland ClinicUnited States 30 works
- 4 Memorial Sloan Kettering Cancer CenterUnited States 30 works
- 5 Sun Yat-sen UniversityChina 29 works
- 6 Fujian Medical UniversityChina 23 works
- 7 Sichuan UniversityChina 22 works
- 8 University of North Carolina at Chapel HillUnited States 21 works
- 9 Peking UniversityChina 16 works
- 10 National Cancer CenterUnited States 15 works
Who are the leading researchers in Colorectal and Anal Carcinomas?
The most-cited researchers publishing on Colorectal and Anal Carcinomas include Ionuţ Negoi, Daniel J. Sargent and Ying Liu.
- 1 Ionuţ Negoi Romania 4.8k citations
- 2 Daniel J. Sargent United States 4.1k citations
- 3 Ying Liu China 3.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Colorectal and Anal Carcinomas research done?
The largest centres of Colorectal and Anal Carcinomas research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Cleveland.
Largest cities, 2022–2025
Where it is the local speciality
- ClevelandUS · 48.2 works6.8×
Location quotient: how much more of its research is in Colorectal and Anal Carcinomas than the world average.
Where is the best place to study Colorectal and Anal Carcinomas?
Among universities, judged by research, Hebei Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College and Fujian Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Hebei Medical UniversityChina | 70.1 | 25.6% | 10.0× | 10 | +153.0% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 64.6 | 13.8% | 8.4× | 40 | +81.4% |
| 3 | Fujian Medical UniversityChina | 56.6 | 8.8% | 13.1× | 22 | +96.0% |
| 4 | Sun Yat-sen UniversityChina | 53.3 | 16.5% | 3.7× | 29 | +126.3% |
| 5 | Icahn School of Medicine at Mount SinaiUnited States | 44.0 | 8.7% | 6.2× | 15 | +134.5% |
| 6 | Shandong First Medical UniversityChina | 42.0 | 15.4% | 7.3× | 9 | +35.0% |
| 7 | Sichuan UniversityChina | 41.3 | 12.1% | 2.6× | 22 | +139.3% |
| 8 | Capital Medical UniversityChina | 40.5 | 21.5% | 3.3× | 9 | +78.0% |
| 9 | University of MiamiUnited States | 38.7 | 16.9% | 4.7× | 11 | +18.2% |
| 10 | Peking UniversityChina | 37.6 | 13.4% | 2.0× | 16 | +125.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Colorectal and Anal Carcinomas research growing?
Output in 2018–2022 was 32% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Colorectal and Anal Carcinomas.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.